Skip to main content
Back
Watch Compare

GT Biopharma, Inc.

Data quality: 83%
GTBP
Nasdaq Manufacturing Chemicals
$0.38
▼ $0.02 (-6.10%)
Mkt Cap: 11.99 M
Price
$0.38
Mkt Cap
11.99 M
Day Range
$0.38 — $0.40
52-Week Range
$0.38 — $3.85
Volume
847,090
Open $0.40
50D / 200D Avg
$0.49
22.08% below
50D / 200D Avg
$1.01
62.46% below

Quick Summary

Key Takeaways

Negative free cash flow of -12.91 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-967.55%
Below sector avg (-53.41%)
ROIC-251.08%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio3.27
Interest Coverage-97.81

Valuation

PE (TTM)
-0.42
Above sector avg (-1.48)
P/B Ratio4.00
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.4 -1.5
P/B 4.0 1.6
ROE % -967.6 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -28.35 M
ROE -967.55% ROA -495.48%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.91 M
ROIC -251.08% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.27
Interest Coverage -97.81 Asset Turnover N/A
Working Capital 3.00 M Tangible Book Value 3.00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.42 Forward P/E N/A
P/B Ratio 4.00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -107.70%
Market Cap 11.99 M Enterprise Value 9.46 M
Per Share
EPS (Diluted TTM) -6.68 Revenue / Share N/A
FCF / Share -0.41 OCF / Share -0.41
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 45.55%
SBC-Adj. FCF -13.30 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -28.35 M -13.16 M -7.60 M -20.88 M -58.01 M
EPS (Diluted) -6.68 -6.94 -5.64 — —
Gross Profit — — — — —
Operating Income -12.42 M -14.36 M -13.58 M -21.26 M -57.52 M
EBITDA — — — — —
R&D Expenses 3.47 M 5.80 M 6.47 M 8.81 M 9.59 M
SG&A Expenses 8.95 M 8.57 M 7.11 M 12.45 M 47.92 M
D&A — — — — —
Interest Expense 127,000.0 213,000.0 213,000.0 8,000.0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.11 M 4.23 M 14.11 M 16.74 M —
Total Liabilities 1.32 M — 6.63 M 5.00 M —
Shareholders' Equity 5.79 M -1.67 M 7.48 M 11.73 M 21.91 M
Total Debt — — — — —
Cash & Equivalents 6.81 M 3.95 M 1.08 M 5.67 M 32.00 M
Current Assets 8.11 M 4.23 M 14.06 M 16.56 M 32.17 M
Current Liabilities 2.32 M 5.90 M 6.63 M 4.94 M 10.26 M